0001209191-17-033224.txt : 20170517
0001209191-17-033224.hdr.sgml : 20170517
20170517170957
ACCESSION NUMBER: 0001209191-17-033224
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170515
FILED AS OF DATE: 20170517
DATE AS OF CHANGE: 20170517
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Myovant Sciences Ltd.
CENTRAL INDEX KEY: 0001679082
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 20-22 BEDFORD ROW
CITY: LONDON
STATE: X0
ZIP: WC1R 4JS
BUSINESS PHONE: (441) 824-8101
MAIL ADDRESS:
STREET 1: 20-22 BEDFORD ROW
CITY: LONDON
STATE: X0
ZIP: WC1R 4JS
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KARBE FRANK
CENTRAL INDEX KEY: 0001276700
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37929
FILM NUMBER: 17852526
MAIL ADDRESS:
STREET 1: C/O ARBUTUS BIOPHARMA CORP.
STREET 2: 100-8900 GLENLYON PARKWAY
CITY: BURNABY
STATE: A1
ZIP: V5J 5J8
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-05-15
0
0001679082
Myovant Sciences Ltd.
MYOV
0001276700
KARBE FRANK
C/O MYOVANT SCIENCES INC.
2000 SIERRA POINT PARKWAY
BRISBANE
CA
94005
0
1
0
0
Principal Fin'l & Accounting
Stock Option (Right to Buy)
12.68
2017-05-15
4
A
0
200000
0.00
A
2027-05-14
Common Shares
200000
200000
D
25% of the shares underlying the option vest and become exercisable on May 15, 2018; the balance of the shares vest and become exercisable in a series of twelve (12) successive equal quarterly installments measured from May 15, 2018, subject to the Reporting Person providing continuous service to the Issuer on each such date.
/s/Alison Haggerty, Attorney-in-Fact
2017-05-17